Resonance Specialties Ltd Stock Price Today (NSE: RESONANCE)

Resonance Specialties Ltd

131.801.10 (0.83%)
Market Closed

Fundamental Score

...

Resonance Specialties Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Resonance Specialties Ltd share price today is 131.80, down 0.83% on NSE/BSE as of 19 June 2026. Resonance Specialties Ltd (RESONANCE) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 113.97 (Cr). The 52-week high for RESONANCE share price is 142.90 and the 52-week low is 77.00. At a P/E ratio of 15.24x, RESONANCE is currently trading below its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 11.65% and a debt-to-equity ratio of 0.04.

Resonance Specialties Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
142.90
Low
95.13
Volume
40.6K
Change
+26.73%

Resonance Specialties Ltd share price chart: 26.73% return over the past month. 52-week high ₹142.90, 52-week low ₹77.00.

Resonance Specialties Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
133.00140.00130.05131.8028.09K (Cr)
129.00133.80124.05132.9032.79K (Cr)
122.52128.77120.05126.2813.52K (Cr)
125.90128.84122.01122.8814.81K (Cr)
129.89130.98120.11125.9027.10K (Cr)
129.18131.00127.04127.4811.53K (Cr)
131.65134.99127.10127.8917.34K (Cr)
134.00139.80130.50131.3624.61K (Cr)
129.80142.90124.11133.371.71L (Cr)
113.20128.00113.20126.401.11L (Cr)

Resonance Specialties Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
129.00140.00124.05131.80+2.17%
100.00142.9099.75126.28+26.28%
82.01101.9982.0199.91+21.83%
91.85100.0077.0077.93-15.16%
105.00118.0095.1597.60-7.05%
101.50109.0090.05107.85+6.26%
95.51106.5090.30101.50+6.27%
98.00101.6587.0195.51-2.54%
101.00103.0091.5098.00-2.97%
100.05106.3597.0099.50-0.55%
116.95121.8598.50101.30-13.38%
114.35122.75109.00122.75+7.35%

AI Research Briefing

Powered by Gemini · 2026-04-15

Micro-cap play on 'China+1' in specialty chemicals; high risk, potentially high reward, but liquidity a major concern.

Research Confidence
6.0/10Moderate
MICRO-CAP DARK HORSEConsolidation - 1M: 0.78%, 3M: -3.32%, 6M: -14.08%Cheap - P/E 11.26x vs. industry P/E 29.2x

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. The most recent news highlights a shift in valuation to 'very attractive' amid mixed market returns. However, Markets Mojo maintains a 'Sell' rating.

CORE STORY (THE REAL GAME)

Resonance is a bet on the 'China+1' shift in specialty chemicals, specifically pyridine derivatives. It's a play on global supply chain diversification, not just a chemical manufacturer.

Why Now
  • Q3 FY26 profit surge of 125.27%
  • Strong export growth, contributing over half of revenue
  • Valuation shift to 'very attractive'
Potential Catalysts
  • Sustained export growth
  • New order wins
  • Further margin expansion
Key Risks
  • Micro-cap liquidity risk
  • Markets Mojo 'Sell' rating
  • Reliance on exports exposes to global headwinds
Institutional Activity

FII/DII holdings negligible. Promoter holding stable at 54.25%.

Macro Context

India's specialty chemicals sector projected to grow strongly, driven by domestic demand and government support.

Cash Flow Quality

No - Negative free cash flow of ₹-3.15 Cr over 5 years

3–6 Month Outlook

If Resonance can sustain its export-led growth and margin expansion, it could re-rate significantly. However, failure to do so will lead to a sharp correction.

Primary Thesis Risk

Inability to sustain export growth will kill the thesis.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

11.65%

Profit generated per ₹1 of shareholder equity

Average

Return on Capital (ROCE)

15.40%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

15.87%

Average operating profit margin over 5 years

Good

Dividend Yield

1.01%

Annual dividend as % of current share price

Resonance Specialties Ltd Valuation Check

Excellent

Price to Earnings (P/E)

15.24x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

29.20x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

54.25%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.03%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-3.49%

Net profit growth vs same quarter last year

Good

Revenue Growth (Quarterly YoY)

19.21%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

6.75%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

1.29%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

1.29%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.04x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

38.57x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-3.15 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Resonance Specialties Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of RESONANCE across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (15.40%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (15.87%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 15.24 vs Industry: 29.20)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Strong Revenue Growth (19.21%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.04)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (38.57x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (54.25%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Weak Earnings Growth (1.29% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (1.29% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Negative Free Cash Flow (₹-3.15 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.03%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Resonance Specialties Ltd vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Resonance Specialties Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
43.5/100
132
₹113.97
15.2
Average
11.65%
Average
15.40%
Good
0.0
Excellent
1.29%
Average
6.75%
Good
1.01%
60.4/100
1481
₹149466.57
66.6
Average
23.05%
Excellent
29.84%
Excellent
0.1
Excellent
12.63%
Good
12.49%
Good
0.68%
51.5/100
3682
₹37241.99
54.8
Average
8.29%
Poor
9.89%
Poor
0.2
Excellent
21.05%
Excellent
12.69%
Good
0.09%
40.6/100
7245
₹29462.02
66.3
Average
11.52%
Average
11.68%
Average
0.3
Excellent
-6.59%
Poor
17.22%
Excellent
0.21%
40.2/100
1715
₹21083.64
39.7
Average
13.36%
Average
16.28%
Good
0.2
Excellent
2.02%
Average
14.38%
Good
0.49%
52/100
3430
₹17807.40
46.3
Average
13.73%
Average
18.02%
Good
0.0
Excellent
57.98%
Excellent
14.83%
Good
0.49%
Atul Ltd...
ATUL500027
50.5/100
7003
₹17066.13
31.5
Average
9.10%
Poor
12.81%
Average
0.0
Excellent
-5.82%
Poor
6.41%
Good
0.43%
57.2/100
1325
₹16256.72
35.0
Average
15.75%
Good
20.61%
Excellent
0.0
Excellent
4.46%
Average
16.92%
Excellent
0.48%
37.5/100
1368
₹14036.52
92.8
Average
3.32%
Poor
7.33%
Poor
0.4
Excellent
11.97%
Good
22.13%
Excellent
0.06%
41.9/100
501
₹13796.68
51.3
Average
6.03%
Poor
6.32%
Poor
0.7
Good
-9.09%
Poor
11.68%
Good
0.26%
60.5/100
4677
₹13359.76
33.4
Average
19.47%
Good
26.39%
Excellent
0.0
Excellent
20.04%
Excellent
16.93%
Excellent
0.25%

Resonance Specialties Ltd PE Ratio History

Historical price-to-earnings ratio for RESONANCE — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20255.65₹101.5018x
FY 20242.56₹97.1037.9x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Resonance Specialties Ltd Dividend History

Annual cash dividends paid by RESONANCE — dividend yield 1.01%

Financial YearDividends Paid (₹ Cr)
FY 20241.15 Cr
FY 20231.15 Cr
FY 20221.15 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Resonance Specialties Ltd Quarterly Performance

Latest quarterly metrics for RESONANCE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

19.21%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-3.49%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

6.75%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

1.29%

Compounded annual net profit growth over 5 years

Resonance Specialties Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for RESONANCE — calculated from daily price history

65RSI 14
Neutral — RSI 65

Momentum is balanced — neither overbought nor oversold.

SMA 50
101
▲ Price above SMA 50 — Short-term bullish
SMA 200
100
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
31K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Resonance Specialties Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Resonance Specialties Ltd (RESONANCE) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Resonance Specialties Ltd

About RESONANCE (Resonance Specialties Ltd)

Resonance Specialties Ltd is a dynamic manufacturer and global supplier of niche specialty chemicals, carving a distinct presence within the fine chemical landscape. With a commitm...ent to innovation and quality, Resonance specializes in the production of intricate chemical compounds essential across diverse industrial applications. Their portfolio comprises an array of meticulously synthesized chemicals designed to meet the stringent demands of industries ranging from agriculture to pharmaceuticals. Resonance distinguishes itself through its dedication to providing customized chemical solutions, partnering closely with clients to develop formulations tailored to their specific needs. By prioritizing research, development, and sustainable practices, Resonance Specialties Ltd is establishing itself as a reliable partner in the global specialty chemicals market. Resonance's core expertise lies in the creation of complex heterocyclic compounds, vital building blocks for a multitude of end-products. Their pyridine derivatives form the backbone of numerous agrochemical formulations, enabling the development of advanced crop protection solutions. In the pharmaceutical sector, Resonance's cyanopyridines play a critical role in the synthesis of essential vitamins and therapeutic agents, contributing to improved healthcare outcomes. Furthermore, their picolines serve as key intermediates in the production of specialized materials like vinyl latex rubber and contribute to the development of anti-tuberculosis treatments. Through meticulous control over reaction processes and rigorous quality assurance protocols, Resonance ensures consistent product purity and performance. Beyond its established product lines, Resonance Specialties Ltd is actively pursuing expansion into new chemical domains and geographical markets. Their commitment to continuous improvement drives ongoing investments in research and development, allowing them to anticipate evolving market needs and develop innovative solutions. By fostering strong relationships with customers and suppliers, Resonance creates a robust ecosystem that supports sustainable growth and mutually beneficial collaborations. With a focus on operational excellence and a dedication to responsible chemical management, Resonance Specialties Ltd is well-positioned to solidify its standing as a trusted provider of high-quality specialty chemicals on a global scale.

Company Details

Symbol:RESONANCE
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Charchit Jain
GM, CFO & Whole-Time Director
Ms. Vaibhavi Rajeshirke
Company Secretary & Compliance Officer

RESONANCE Share Price: Frequently Asked Questions

What is the current share price of Resonance Specialties Ltd?

Resonance Specialties Ltd (RESONANCE) trades at ₹131.80 on NSE and BSE. Market cap ₹113.97 (Cr). Educational data only.

What is the P/E ratio of Resonance Specialties Ltd?

Resonance Specialties Ltd has a P/E of 15.24x vs industry average 29.20x.

What is the Bull Run score for Resonance Specialties Ltd?

Resonance Specialties Ltd has a Bull Run score of 43.5/100 based on 25+ financial parameters.

Does Resonance Specialties Ltd pay dividends?

Resonance Specialties Ltd has a dividend yield of 1.01%. Past dividends don't guarantee future payments.

What is the ROE of Resonance Specialties Ltd?

Resonance Specialties Ltd has ROE of 11.65%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Resonance Specialties Ltd?

Resonance Specialties Ltd has debt-to-equity of 0.04.

Is Resonance Specialties Ltd a good investment?

Bull Run gives Resonance Specialties Ltd a score of 43.5/100. This is not investment advice — consult a SEBI-registered advisor.